Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

GDOC vs ETIHX overlap: 16% of top holdings shared

Bottom line

How much do GDOC and ETIHX overlap?

16% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 14.2% of GDOC's assets and 15.1% of ETIHX's. They are substantially different portfolios, so owning both adds real diversification.

ETIHX holds far more positions (93 vs 42), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

GDOCETIHX
Weight overlap (top 25)16%
Shared holdings5
Weight in shared holdings14.2%15.1%
Total positions4293
Expense ratio0.75%1.29%
Holdings as ofMay 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Holdings GDOC and ETIHX have in common

Holding% of GDOC% of ETIHXOverlap
Guardant Health Inc GH5.34%5.37%5.34%
Argenx Se ARGX4.07%2.55%2.55%
Apogee Therapeutics Inc APGE1.97%1.93%1.93%
Cytokinetics Inc CYTK1.40%2.69%1.40%
Ionis Pharmaceuticals Inc IONS1.37%2.55%1.37%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in GDOC

  1. Eli Lilly & Company — 13.28%
  2. Johnson & Johnson — 8.07%
  3. Merck & Company Inc — 5.94%
  4. Astrazeneca Plc — 4.84%
  5. Thermo Fisher Scientific Inc — 4.52%
  6. Intuitive Surgical Inc — 3.90%
  7. Boston Scientific Corp — 3.78%
  8. Hoya Corp — 3.53%
  9. Edwards Lifesciences Corp — 2.98%
  10. Lonza Group Ag — 2.80%
  11. Dexcom Inc — 2.79%
  12. Agilent Technologies Inc — 2.77%
  13. Roivant Sciences Ltd — 2.39%
  14. Cencora Inc — 2.34%
  15. Royalty Pharma Plc — 1.77%

Only in ETIHX

  1. US Bank Mmda — 3.75%
  2. Mirum Pharmaceuticals Inc — 3.47%
  3. Kymera Therapeutics Inc — 3.22%
  4. Abivax Sa — 2.94%
  5. BeLite Bio Inc — 2.83%
  6. Trevi Therapeutics Inc — 2.77%
  7. Mbx Biosciences Inc — 2.70%
  8. Vaxcyte Inc — 2.69%
  9. Insmed Inc — 2.40%
  10. Revolution Medicines Inc — 2.36%
  11. Avalyn Pharma Inc — 2.35%
  12. Immix Biopharma Inc — 2.24%
  13. Celldex Therapeutics Inc — 2.16%
  14. Palvella Therapeutics Inc — 1.98%
  15. Kestra Medical Technologies Ltd — 1.95%

Asset mix

Asset typeGDOCETIHX
Stocks98.5%94.2%
Cash & short-term funds1.4%5.2%
Preferred stock—1.4%
DO—0.2%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Country mix

CountryGDOCETIHX
US76.3%90.2%
GB6.6%—
NL4.1%2.6%
CH3.9%—
JP3.5%—
FR0.6%2.9%
BM2.4%2.0%
CA1.9%2.4%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do GDOC and ETIHX overlap?
About 16% by weight. 5 securities appear in both funds' top 25 holdings; they make up 14.2% of GDOC's assets and 15.1% of ETIHX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do GDOC and ETIHX have in common?
The largest shared holdings are Guardant Health Inc, Argenx Se, Apogee Therapeutics Inc, Cytokinetics Inc, Ionis Pharmaceuticals Inc.
Should I own both GDOC and ETIHX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, GDOC or ETIHX?
ETIHX is broader, with 93 positions versus 42 for GDOC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.